Patents Assigned to Foundation
-
Publication number: 20100044212Abstract: A vertically standing IPMC includes a substrate, a first electrode positioned substantially vertical with respect to an upper surface of the substrate, a second electrode positioned substantially vertical with respect to the upper surface of the substrate and disposed opposite to the first electrode, and an ionic polymer film interposed between the first electrode and the second electrode and standing substantially vertical with respect to the upper surface of the substrate.Type: ApplicationFiled: August 21, 2008Publication date: February 25, 2010Applicant: SNU R&DB FoundationInventors: Yong Hyup Kim, Seong Jun Kim
-
Publication number: 20100045778Abstract: A system and a method for acquiring an image of a particle flowing in a vessel, the system comprising a light source for generating an illuminating light, an imaging probe for laterally statically illuminating at least a portion of said vessel with the illuminating light, a detection unit for detecting emitted light from an illuminated portion of said particle, and a processor unit for reproducing an image of the illuminated portion of said particle from the emitted light.Type: ApplicationFiled: August 17, 2009Publication date: February 25, 2010Applicant: Technion Research & Development Foundation Ltd.Inventor: Dvir Yelin
-
Publication number: 20100047570Abstract: Techniques for preparing polymer nanocomposites (PNCs) are provided. In one embodiment, a polymer extruding device includes a barrel configured to accommodate a raw material, a shaft disposed in the barrel, a motor coupled to the shaft and configured to rotate the shaft to move the raw material, and a die coupled to the barrel and including one or more first injector configured to inject nanoparticles into the die, thereby forming a layer of the nanoparticles on a surface of the raw material. The polymer extruder may further include a rotor disposed at one end of the die and configured to receive the raw material from the die.Type: ApplicationFiled: August 25, 2008Publication date: February 25, 2010Applicant: SNU R&DB FoundationInventor: Youngtack Shim
-
Publication number: 20100047146Abstract: A promoted activated carbon sorbent is described that is highly effective for the removal of mercury from flue gas streams. The sorbent comprises a new modified carbon form containing reactive forms of halogen and halides. Optional components may be added to increase reactivity and mercury capacity. These may be added directly with the sorbent, or to the flue gas to enhance sorbent performance and/or mercury capture. Mercury removal efficiencies obtained exceed conventional methods. The sorbent can be regenerated and reused. Sorbent treatment and preparation methods are also described. New methods for in-flight preparation, introduction, and control of the active sorbent into the mercury contaminated gas stream are described.Type: ApplicationFiled: April 6, 2009Publication date: February 25, 2010Applicant: Energy & Environmental Research Center FoundationInventors: Edwin S. Olson, Michael J. Holmes, John H. Pavlish
-
Publication number: 20100048714Abstract: Disclosed are compositions and methods related to the ceramide synthesis pathway and various diseases and disorders associated therewith, such as insulin resistance and inflammation.Type: ApplicationFiled: June 19, 2007Publication date: February 25, 2010Applicant: University of Utah Research FoundationInventor: Scott A. Summers
-
Patent number: 7666599Abstract: Aspects of the present invention provide novel compositions and methods based on novel calpastatin (CAST) genetic markers, such as missense mutations in exon 3 that result in G48D or P52L substitutions (NM_174003.2:c.271G>A and 283C>T), a G/T substitution in intron 3 (AAFC02060381.1:g.2110G>T) and a GAAA repeat in intron 8 (AAFC02060381.1:g.6700[(GAAA)4]+[(GAAA)5]. Particular aspects provide novel markers for fertility (e.g., daughter pregnancy rate, DPR) and longevity (e.g., productive life, PL) in, for example, dairy cattle. Additional aspects provide for novel methods comprising marker-assisted selection to improve fertility and/or longevity in dairy cattle. Therefore, in particular embodiments, a combination of genetic selection based on one or more of the novel CAST markers, and high PTA potentials of milk production traits, provides for improved reproductive traits in association with continued high milk production traits.Type: GrantFiled: January 5, 2007Date of Patent: February 23, 2010Assignee: Washington State University Research FoundationInventors: Zhihua Jiang, Jennifer J. Michal, Matthew D. Garcia
-
Patent number: 7667006Abstract: The present invention aims at providing a high affinity anti-HIV antibody. According to the present invention, there are provided an antibody or a fragment thereof that binds to the gp12 glycoprotein of HIV and has a dissociation constant (KD) value of 1.0×10?9 (M) or less; a pharmaceutical composition comprising the antibody or fragment thereof; and a method of producing an anti-HIV antibody or a fragment thereof, comprising immunizing a GANP transgenic non-human mammal or a progeny thereof with a polypeptide consisting of the amino acid sequence as shown in SEQ ID NO: 6 as an antigen and collecting the antibody from the resultant mammal or progeny.Type: GrantFiled: March 9, 2004Date of Patent: February 23, 2010Assignee: Kumamoto Technology and Industry FoundationInventors: Nobuo Sakaguchi, Kazuhiko Kuwahara, Chiemi Minoda
-
Patent number: 7667783Abstract: Systems, methods, apparatus and devices for head mounted stereoscopic 3-D display devices using the tunable focus liquid crystal micro-lens array eye to produce eye accommodation information. A liquid crystal display panel displays stereoscopic images and uses tunable liquid crystal micro-lens array to change the diopter of the display pixels to provide eye accommodation information. The head mounted display device includes a planar display screen, planar tunable liquid crystal micro-lens array and planar black mask. The display device may optionally include a bias lens. In an embodiment, the display device also includes a backlight and a prism sheet for displaying the images on the display screen. The display screen, tunable liquid crystal micro-lens array, black mask and optional backlight and prism may be flat or curved.Type: GrantFiled: June 1, 2007Date of Patent: February 23, 2010Assignees: University of Central Florida Research Foundation, Inc., Toppoly Optoelectronics Corp.Inventors: Qi Hong, Ruibo Lu, Thomas Xinzhang Wu, Shin-Tson Wu
-
Patent number: 7666656Abstract: Mycobacterium strains that have an enhanced ability to elicit a MHC-Class I-restricted CD8+ T cell immune response are provided. The Mycobacterium strains are genetically engineered to express: a endosomolytic protein that is active at neutral pH (e.g. Perfringolysin O), permitting escape of the Mycobacterium from endosomes into the cytoplasm of the cell; and antigens of interest, such as tuberculosis antigens. The invention also provides vaccine preparations containing such Mycobacterium strains.Type: GrantFiled: May 31, 2007Date of Patent: February 23, 2010Assignee: Aeras Global TB Vaccine FoundationInventors: Ronggai Sun, David Michael Hone, Jerald C. Sadoff
-
Patent number: 7665967Abstract: Efficient traditionally appearing ceiling fan blades with aerodynamical upper surfaces and wide tip ends for ceiling fans with blades formed from plastic and/or wood and/or separately attached surfaces that run at reduced energy consumption that move larger air volumes than traditional flat shaped ceiling fan blades. And methods of operating the novel ceiling fans blades for different speeds of up to and less than approximately 250 rpm. The novel blades twisted blades can be configured for ceiling fans having any diameters from less than approximately 32 inches to greater than approximately 64 inch fans, and can be used in two, three, four, five and more blade configurations. The novel fans can be run at reduced speeds, drawing less Watts than conventional fans and still perform better with more air flow and less problems than conventional flat type conventional flat and planar upper and lower surface blades.Type: GrantFiled: March 24, 2006Date of Patent: February 23, 2010Assignee: University of Central Florida Research Foundation, Inc.Inventors: Danny S. Parker, Bart Hibbs
-
Patent number: 7667009Abstract: A method for purifying a modified major mite allergen obtained by the genetic recombination technique and a purified modified major mite allergen obtained by said method for purification are provided.Type: GrantFiled: April 14, 2004Date of Patent: February 23, 2010Assignee: Juridical Foundation the Chemo-Sero-Therapeutic Research InstituteInventors: Satoshi Koyanagi, Kenjiro Kawatsu, Toshio Murakami, Yoshinobu Miyatsu, Toshihiro Maeda, Hiroshi Mizokami
-
Patent number: 7665226Abstract: An apparatus and a method for drying under reduced pressure using microwaves. The apparatus comprises a chamber (13) for housing an object (11), a depressurizing pump (22) connected to the chamber (13) for depressurizing the inside of the chamber (13), a microwave irradiating device (12) for irradiating microwaves to the object (11) in the chamber (13), an airflow generating device for generating an airflow in the chamber (13) by introducing a gas from the outside to the inside of the chamber (13), and a control device (35) for controlling the above components. The object (11) in the chamber (13) is dried at temperatures below a deterioration temperature of the object (11) by intermittent irradiation of the microwaves under reduced pressure while the airflow is generated around the object (11).Type: GrantFiled: April 11, 2005Date of Patent: February 23, 2010Assignees: Kitakyushu Foundation for the Advancement of Industry, Science & Technology, Fukuoka Prefectural GovernmentInventors: Takaharu Tsuruta, Tadahisa Hayashi
-
Patent number: 7667090Abstract: A transgenic non-human animal, such as a mouse, has a genome that include a nucleic acid construct having at least one transcriptional regulatory sequence capable of directing expression in B cells of the animal, wherein the transcriptional regulatory sequence is operably linked to a nucleic acid encoding a miR155 gene product. A method of testing the therapeutic efficacy of an agent in treating or preventing a lymphoproliferative condition includes assessing the effect(s) of the agent on a transgenic non-human animal.Type: GrantFiled: April 24, 2007Date of Patent: February 23, 2010Assignee: The Ohio State University Research FoundationInventor: Carlo M. Croce
-
Patent number: 7667013Abstract: A gene encoding a novel protein that works as a guanine nucleotide exchange factor (GEF) for a Rho family protein being one group of small GTP-binding proteins, namely, a polynucleotide shown by the nucleotide sequence set forth in SEQ ID NO: 1, SEQ ID NO: 3, or SEQ ID NO: 5, or the complementary strand, the equivalents of the polynucleotide, a protein encoded by the polynucleotide, a vector containing the polynucleotide, a transformant containing the vector, an antibody against the protein encoded by the polynucleotide, a method of identifying a compound that inhibits the function of the protein encoded by the polynucleotide and/or the expression of the polynucleotide, a method of determining a disease, a pharmaceutical composition, and a reagent kit are provided.Type: GrantFiled: March 29, 2005Date of Patent: February 23, 2010Assignees: Daiichi Sankyo Company, Limited, Kazusa DNA Research Institute FoundationInventors: Osamu Ohara, Takahiro Nagase, Michio Oishi, Hiroshi Yokota, Osamu Kamida
-
Patent number: 7666259Abstract: In one embodiment, a crystallization and screening plate comprises a plurality of cells open at a top and a bottom, a frame that defines the cells in the plate, and at least two films. The first film seals a top of the plate and the second film seals a bottom of the plate. At least one of the films is patterned to strongly pin the contact lines of drops dispensed onto it, fixing their position and shape. The present invention also includes methods and other devices for manual and high-throughput protein crystal growth.Type: GrantFiled: August 8, 2006Date of Patent: February 23, 2010Assignee: Cornell Research Foundation, Inc.Inventors: Robert E. Thorne, Viatcheslav Berejnov, Yevgeniy Kalinin
-
Patent number: 7667025Abstract: The invention provides methods to detect herpes simplex virus (HSV) in biological samples and further to distinguish between HSV-1 and HSV-2. Primers and probes for the differential detection of HSV-1 and HSV-2 are provided by the invention. Articles of manufacture containing such primers and probes for detecting HSV are further provided by the invention.Type: GrantFiled: May 27, 2005Date of Patent: February 23, 2010Assignee: Mayo Foundation for Medical Education and ResearchInventors: Thomas F. Smith, Arlo Wold, Jim Uhl, Mark J. Espy
-
Patent number: 7666431Abstract: Fusion of the membrane of enveloped viruses with the plasma membrane of a receptive host cell is a prerequisite for viral entry and infection and an essential step in the life cycle of all enveloped viruses, such as paramyxoviruses. The instant invention is directed to providing polypeptides which are a heptad portion of a Henipavirus F protein effective against fusion between a membrane of a paramyxovirus and a plasma membrane of a cell. The instant invention also provides nucleic acids, compositions, and methods effective against paramyxovirus infection. Accordingly, the instant invention provides therapeutic agents and vaccines effective against paramyxoviruses viruses, especially HeV or NiV.Type: GrantFiled: November 13, 2002Date of Patent: February 23, 2010Assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.Inventors: Christopher C. Broder, Katharine N. Bossart
-
Patent number: 7666425Abstract: The present invention is directed to the use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen. These biological agents can be labeled and used for detection of normal, benign hyperplastic, and cancerous prostate epithelial cells or portions thereof. They also can be used alone or bound to a substance effective to ablate or kill such cells as a therapy for prostate cancer. Also disclosed are four hybridoma cell lines, each of which produces a monoclonal antibody recognizing extracellular domains of prostate specific membrane antigens of normal, benign hyperplastic, and cancerous prostate epithelial cells or portions thereof.Type: GrantFiled: July 20, 1999Date of Patent: February 23, 2010Assignee: Cornell Research Foundation, Inc.Inventor: Neil H. Bander
-
Patent number: 7667096Abstract: The present disclosure provides methods, recombinant DNA molecules, recombinant host cells containing the DNA molecules, and transgenic plant cells, plant tissue and plants which contain and express at least one antisense or interference RNA specific for a thiamine biosynthetic coding sequence or a thiamine binding protein or a thiamine-degrading protein, wherein the RNA or thiamine binding protein is expressed under the regulatory control of a transcription regulatory sequence which directs expression in male and/or female reproductive tissue. These transgenic plants are conditionally sterile; i.e., they are fertile only in the presence of exogenous thiamine. Such plants are especially appropriate for use in the seed industry or in the environment, for example, for use in revegetation of contaminated soils or phytoremediation, especially when those transgenic plants also contain and express one or more chimeric genes which confer resistance to contaminants.Type: GrantFiled: June 3, 2004Date of Patent: February 23, 2010Assignee: University of Georgia Research Foundation, Inc.Inventors: Richard B. Meagher, Elizabeth McKinney, Tehryung Kim
-
Patent number: PP20792Abstract: A new and distinct cultivar of caladium named ‘Cranberry Star’, characterized by its heart-shaped leaves, bright white color and numerous purple spots, and demonstrated potential to produce attractive plants when forced in containers without de-eyeing and/or when grown in outdoor shady landscapes.Type: GrantFiled: June 26, 2008Date of Patent: February 23, 2010Assignee: Florida Foundation Seed Producers, Inc.Inventors: Zhanao Deng, Brent Harbaugh